HUP0000943A2 - Expandálható gasztro-retentív terápiás rendszer szabályozott hatóanyag felszabadítással a gyomor-béltraktusban - Google Patents

Expandálható gasztro-retentív terápiás rendszer szabályozott hatóanyag felszabadítással a gyomor-béltraktusban

Info

Publication number
HUP0000943A2
HUP0000943A2 HU0000943A HUP0000943A HUP0000943A2 HU P0000943 A2 HUP0000943 A2 HU P0000943A2 HU 0000943 A HU0000943 A HU 0000943A HU P0000943 A HUP0000943 A HU P0000943A HU P0000943 A2 HUP0000943 A2 HU P0000943A2
Authority
HU
Hungary
Prior art keywords
gastro
active substance
expandable
retentive
intestinal tract
Prior art date
Application number
HU0000943A
Other languages
English (en)
Inventor
Bodo Asmussen
Karsten Cremer
Hans-Rainer Hoffmann
Karin Ludwig
Michael Roreger
Original Assignee
Lts Lohmann Therapie-Systeme Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Gmbh filed Critical Lts Lohmann Therapie-Systeme Gmbh
Publication of HUP0000943A2 publication Critical patent/HUP0000943A2/hu
Publication of HUP0000943A3 publication Critical patent/HUP0000943A3/hu
Publication of HU224224B1 publication Critical patent/HU224224B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Anesthesiology (AREA)
  • Wood Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány egy gyógyszerformát ír le hatóanyagok szabályozottfelszabadításához a gyomor-bél-traktusban késleltetett pylorus-pasz-százzsal egy a gyomornedvvel érintkező expandálható komponenssel, melyvalamely a gyomornedv és hatóanyagok számára permeábilispolimerburokkal van körülvéve. A gyógyszerforma legalább egyhatóanyagot tartalmaz, mely valamely multipartikuláris készítménybenvan, mely a hatóanyagot retardálva a gyomornedvbe lead. Szemben aszokásos gyógyszerformákkal, késleltetett pylorus-passzázzsal ahatóanyag-felszabadítás egy találmány szerinti gyógyszerformábóljobban szabályozható; hasonlóképpen a gyógyszerforma könnyen sodorhatóvagy redőzhető és problémamentesen vihető be a kapszulákba. Ó
HU0000943A 1997-01-14 1998-01-09 Expandálható gasztroretentív terápiás rendszer szabályozott hatóanyagfelszabadulással a gyomor-bél traktusban HU224224B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19700915 1997-01-14
PCT/EP1998/000099 WO1998031341A1 (de) 1997-01-14 1998-01-09 Expandierbares gastroretentives therapie-system mit kontrollierter wirkstofffreisetzung im gastrointestinaltrakt

Publications (3)

Publication Number Publication Date
HUP0000943A2 true HUP0000943A2 (hu) 2000-10-28
HUP0000943A3 HUP0000943A3 (en) 2000-11-28
HU224224B1 HU224224B1 (hu) 2005-06-28

Family

ID=7817288

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000943A HU224224B1 (hu) 1997-01-14 1998-01-09 Expandálható gasztroretentív terápiás rendszer szabályozott hatóanyagfelszabadulással a gyomor-bél traktusban

Country Status (20)

Country Link
US (1) US6290989B1 (hu)
EP (1) EP0961611B1 (hu)
JP (1) JP3825811B2 (hu)
KR (1) KR100503266B1 (hu)
AT (1) ATE214916T1 (hu)
AU (1) AU727753B2 (hu)
CA (1) CA2277277C (hu)
CZ (1) CZ297098B6 (hu)
DE (2) DE19800523C2 (hu)
DK (1) DK0961611T3 (hu)
ES (1) ES2175676T3 (hu)
HU (1) HU224224B1 (hu)
ID (1) ID22698A (hu)
IL (1) IL130872A (hu)
NO (1) NO993383L (hu)
NZ (1) NZ336691A (hu)
PL (1) PL193282B1 (hu)
PT (1) PT961611E (hu)
SK (1) SK93999A3 (hu)
WO (1) WO1998031341A1 (hu)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19822278A1 (de) * 1998-05-18 1999-12-02 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoff im Gastrointestinaltrakt mit verzögerter Pyloruspassage
DE19837073A1 (de) * 1998-08-17 2000-03-23 Lohmann Therapie Syst Lts Folienförmige Wirkstoffträger
DE19849848A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung
DE19850309A1 (de) * 1998-10-30 2000-05-04 Lohmann Therapie Syst Lts Expandierbares gastroretensives Therapiesystem mit verlängerter Magenverweildauer
DE19920854A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Verfahren und Vorrichtung zum Herstellen eines gastroretentiven flachen Schlauchbeutels mit Längsnaht
DE19920838A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Gastroretentives System mit Kapillaren
DE19920833A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Gastroretentives System mit quellbaren Polymeren
DE19920837A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Gastroretentives System für verlängerte Verweilzeit im Magen bzw. im Gastrointestinaltrakt
DE19920855A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Magenvolumenreduzierende Darreichungsform
MXPA02007254A (es) 2000-02-04 2002-12-09 Depomed Inc Forma de dosis de cubierta-y-nucleo que se aproxima a liberacion de droga de orden cero.
GB0102725D0 (en) * 2001-02-02 2001-03-21 Stowic Resources Ltd Medical delivery system
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
AU2002356719A1 (en) * 2001-12-17 2003-06-30 Gunther Beisel Agent for oral administration and method for producing the same
US6869333B2 (en) * 2002-09-11 2005-03-22 National Optronics, Inc. Lens blank alignment and blocking device and method
WO2004032906A1 (en) * 2002-10-11 2004-04-22 Depomed Development, Ltd. Gastro-retentive levodopa delivery form
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
EP1786378A2 (en) * 2004-07-30 2007-05-23 Merrion Research II Limited Improved process and machine for automated manufacture of gastro-retentive devices
US8852083B2 (en) * 2005-02-04 2014-10-07 Uti Limited Partnership Self-stabilized encapsulated imaging system
WO2006088305A1 (en) * 2005-02-15 2006-08-24 Chong Kun Dang Pharmaceutical Corp. Gastric-retentive controlled release mono-matrix tablet
JP2009523175A (ja) * 2006-01-10 2009-06-18 パイペックス，インコーポレイテッド 目標とされる安定な銅状態を達成及び維持して銅関連中枢神経系疾患を予防及び治療するための医薬組成物及び方法
MX2008012587A (es) * 2006-03-29 2009-01-14 Electronic Dietary Foods Inc Implemento ingerible para control de peso.
US9579227B2 (en) * 2006-03-29 2017-02-28 Eat Little Inc. Ingestible implement for weight control
US8795721B2 (en) * 2006-12-18 2014-08-05 Eatlittle Inc. Device for delivery of a substance
US20080286343A1 (en) * 2007-05-16 2008-11-20 Dzenana Cengic Solid form
EP2490677A2 (en) * 2009-10-19 2012-08-29 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
US20140343452A1 (en) * 2011-12-21 2014-11-20 Eatlittle Inc. Pseudobezoar-Based Intraluminal Gastrointestinal Cleansing and Biospy
CA3201057A1 (en) 2020-12-08 2022-06-16 Mark Christopher LAY Improvements to devices and methods for delivery of substances to animals

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207890A (en) 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
DE3400106A1 (de) 1984-01-04 1985-07-11 Klaus-Dieter Dr. 3550 Marburg Bremecker Pharmazeutische zubereitungen mit gesteuerter arzneistoff-freisetzung
JPS63501794A (ja) * 1985-10-09 1988-07-21 デジテイン　アルツナイミツテル　ゲ−エムベ−ハ− 医薬有効物質，試薬，その他の作用物質の提供ないし投与形態の製造法
IL87710A (en) * 1987-09-18 1992-06-21 Ciba Geigy Ag Covered floating retard form for controlled release in gastric juice
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
CA2085871C (en) * 1991-12-27 2002-05-07 Gerald S. Rork A controlled release drug dispersion delivery device
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
US5260069A (en) 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen

Also Published As

Publication number Publication date
CZ297098B6 (cs) 2006-09-13
DE19800523C2 (de) 1999-01-21
KR20000070179A (ko) 2000-11-25
US6290989B1 (en) 2001-09-18
ES2175676T3 (es) 2002-11-16
NZ336691A (en) 2000-05-26
CZ249599A3 (cs) 2000-01-12
DK0961611T3 (da) 2002-07-15
SK93999A3 (en) 2000-01-18
AU6292298A (en) 1998-08-07
WO1998031341A1 (de) 1998-07-23
NO993383D0 (no) 1999-07-08
PL193282B1 (pl) 2007-01-31
IL130872A0 (en) 2001-01-28
AU727753B2 (en) 2000-12-21
JP2001508068A (ja) 2001-06-19
IL130872A (en) 2004-02-19
HUP0000943A3 (en) 2000-11-28
JP3825811B2 (ja) 2006-09-27
PL334834A1 (en) 2000-03-27
DE19800523A1 (de) 1998-07-30
NO993383L (no) 1999-07-08
ID22698A (id) 1999-12-09
KR100503266B1 (ko) 2005-07-25
HU224224B1 (hu) 2005-06-28
DE59803511D1 (de) 2002-05-02
PT961611E (pt) 2002-09-30
ATE214916T1 (de) 2002-04-15
CA2277277A1 (en) 1998-07-23
CA2277277C (en) 2005-03-08
EP0961611A2 (de) 1999-12-08
EP0961611B1 (de) 2002-03-27

Similar Documents

Publication Publication Date Title
HUP0000943A2 (hu) Expandálható gasztro-retentív terápiás rendszer szabályozott hatóanyag felszabadítással a gyomor-béltraktusban
CA2344672A1 (en) Expandable gastroretentive therapy system having a prolonged gastric residence time
WO2001056544A3 (en) Shell-and-core dosage form approaching zero-order drug release
WO2001052848A3 (en) Functional coating of linezolid microcapsules for oral administration
CO4940409A1 (es) Tableta cubierta con pelicula para seguridad mejorada del tracto gastrointestinal superior
ES2172239T3 (es) Sistema osmotico de liberacion de farmacos.
ES2079183T3 (es) Formas de dosificacion oral de liberacion retardada para el tratamiento de trastornos intestinales.
ATE277594T1 (de) Vorrichtungen um eine verlängerte medikamententherapie zu erreichen
HUP0100095A2 (hu) Kettős kapszula hatóanyagok adagolására többhatóanyagos terápiában
EA200200126A1 (ru) Гидродинамически сбалансированная пероральная система доставки лекарства
IT1245890B (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
WO2002047607A3 (en) Process for the preparation of a fast dissolving dosage form
RU99118887A (ru) Применение ингибиторов желудочно-кишечной липазы
RU2006115784A (ru) Применение l-бутилфталида для изготовления лекарственного средства для профилактики и лечения церебрального инфаркта
ATE234608T1 (de) Mikrokapseln mit verzögerter freisetzung von wirkstoffen
EA199900963A1 (ru) Лекарственные формы сертралина в виде раствора, заключенного в желатиновые капсулы
GB9910773D0 (en) Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
NO980384D0 (no) Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler
WO2003037301A3 (en) Oral dosage forms for improving the bioavailability of therapeutic agents
TH57760B (th) การลำเลียงยาสู่ลำไส้เล็กและลำไส้ใหญ่โดยใช้แคปซูลชนิด hpmc
MXPA01011964A (es) Forma de unidad de dosis farmaceutica del tipo de capsulas rigidas que contiene clonixinato de lisina, procedimiento para su preparacion y el uso de dicha unidad de dosis como analgesico y7o antiinflamatorio.
AU2002349934A1 (en) Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
TH1131B (th) การใช้ทรานเนซามิก แอสิดในทางเภสัชกรรมสำหรับการบำบัดรอยดำบนผิวหนัง
TH52797B (th) รูปแบบการบริหารยาโดยการรับประทาน

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20050509

MM4A Lapse of definitive patent protection due to non-payment of fees